Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03728608 · ClinicalTrials.gov registry record · NA
Optimal Feeding Tube Dwell Time in VLBW Infants to Reduce Feeding Tube Contamination
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 151
- Enrollment target
NCT03728608: Completed NA study, sponsored by University of Florida.
NCT03728608 is a NA study that has completed, run by University of Florida. The registered enrollment target is 151 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03728608, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 151 participants
- Enrollment target
Study Summary
The study team will determine whether a decreased feeding tube dwell time will reduce feeding tube contamination
Primary Outcome
prepared solution of sectioned feeding tubes will be plated on Agar. After 24 hrs of incubation, unique colony types will be counted.
Interventions
- DEVICE Feeding tube dwell time of 48 hours
- DEVICE Feeding tube dwell time of 7 day
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2017-05-10 |
| Est. Completion | 2023-05-31 |
| Phase | NA |
What the finished NCT03728608 record still lists
NCT03728608 is an interventional study that assigns participants to a tested intervention. The registered 151 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which Feeding tube dwell time of 48 hours is the first listed.
NCT03728608 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03728608 about?
NCT03728608 is a clinical study titled "Optimal Feeding Tube Dwell Time in VLBW Infants to Reduce Feeding Tube Contamination". The study team will determine whether a decreased feeding tube dwell time will reduce feeding tube contamination
What is the current status of trial NCT03728608?
This trial is currently completed. It is a NA study. The enrollment target is 151 participants. The study started on 2017-05-10. Estimated completion is 2023-05-31.
What interventions are being tested in trial NCT03728608?
The interventions under investigation include: Feeding tube dwell time of 48 hours (DEVICE), Feeding tube dwell time of 7 day (DEVICE).
Who is sponsoring clinical trial NCT03728608?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03728608's enrollment target sits among peer trials
151 661st of 2000 higher than 1,340 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01409161 · 151 participants · Phase 2
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
- NCT04245397 · 151 participants · Phase 1
Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
- NCT05761223 · 151 participants · Phase 1
A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849
- NCT07195656 · 151 participants · NA
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI